Individuals with the GSTP1 C haplotype, characterized by the co-occurrence of the GSTP1 Val rs1695 and rs1138272 variants, have a 5.46-fold increased risk of prostate cancer.72 This evidence concerns the gene GSTP1 and prostate carcinoma.